Program and summary of the meeting (in Norwegian)
Published in major journals, first or last author from Oslo University Hospital.
A heterozygous germline CD100 mutation in a family with primary sclerosing cholangitis
Sci Transl Med, 13 (582)
Patient-tailored design for selective co-inhibition of leukemic cell subpopulations
Sci Adv, 7 (8)
Constructive criticism or distortion of the humanitarian narrative? - Authors' reply
Lancet Glob Health, 9 (3), e255